2 UK dividend stocks I’d buy in July

Dividends make a significant contribution to overall stock market returns. Here, Edward Sheldon lists two UK dividend stocks he’d buy in July.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Dividend stocks play a valuable role in my investment portfolio. Not only do they provide me with two sources of return but they also add balance to my portfolio, which has more of a growth focus.

Here, I’m going to discuss two UK dividend stocks I’d be happy to buy today. Both have good long-term dividend track records and I believe they’ve the potential to deliver strong total returns (capital gains plus dividends) in the long run.

A top UK dividend stock

One UK dividend stock that strikes me as a ‘buy’ right now is Hargreaves Lansdown (LSE: HL). It operates the UK’s largest investment platform. At present, the stock offers a prospective yield of a little under 3%.

Hargreaves Lansdown has been a top dividend stock in recent years. Not only has the company increased its payout significantly, but it’s also paid out a number of special dividends. Last financial year, it rewarded investors with a special dividend of 17.4p per share.

I expect this dividend bonanza to continue. Across the UK, interest in investing and trading is very high right now and Hargreaves Lansdown is benefitting. In the four months to 30 April, the company added 126,000 new customers. This growth should help push revenue, earnings and dividends up. For the year ended 30 June, City analysts expect revenue growth of 14%.

There are risks to the investment case, of course. One I’m keeping an eye on is the rising level of competition. New entrants to the market, such as Trading 212 and Freetrade, are capturing market share. Hargreaves Lansdown may have to lower its fees to remain competitive. This could hit its profits and slow the growth of the dividend.

Overall however, I think the stock’s risk/reward profile is attractive. Its forward-looking P/E ratio of 27.9 seems quite reasonable, to my mind, given the company’s growth track record and future prospects.

A dividend champion

Another UK dividend stock I like right now is Smith & Nephew (LSE: SN), the leading medical device company. The prospective yield here is about 1.7%.

There are a number of things I like about Smith & Nephew from a dividend investing point of view. Firstly, the company has an amazing dividend track record — it’s paid out every single year since 1937. Even last year, when many FTSE 100 companies slashed their dividends due to Covid-19, it continued to do so.

Secondly, the company has solid growth prospects in both the short- and long term. In the short term, it should benefit as the global economy reopens and elective medical procedures are resumed. In the long term, it should benefit from an ever-growing ageing population.

In terms of risks, one is Covid-19 setbacks. Further lockdowns could hit revenues and profits. Another is competition from other medical device manufacturers.

Overall however, I’m very bullish on this dividend stock. It’s worth noting that analysts at Credit Suisse recently upgraded SN to ‘outperform’ from ‘neutral’ on the back of reopening optimism. The broker raised its price target to 1,805p — about 14% above the current share price.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares of Hargreaves Lansdown and Smith & Nephew. The Motley Fool UK has recommended Hargreaves Lansdown and Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »